Search

Eric Olson

Examiner (ID: 316, Phone: (571)272-9051 , Office: P/1673 )

Most Active Art Unit
1623
Art Unit(s)
1693, 1673, 1623
Total Applications
1758
Issued Applications
971
Pending Applications
175
Abandoned Applications
632

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 9174981 [patent_doc_number] => 20130316967 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-11-28 [patent_title] => 'COMPOUNDS AND METHODS FOR ENHANCING ERYTHROPOIESIS' [patent_app_type] => utility [patent_app_number] => 13/930849 [patent_app_country] => US [patent_app_date] => 2013-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 6346 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13930849 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/930849
Compounds and methods for enhancing erythropoiesis Jun 27, 2013 Issued
Array ( [id] => 9477814 [patent_doc_number] => 20140135277 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-05-15 [patent_title] => 'SODIUM GLUCOSE CO-TRANSPORTER INHIBITORS AND METHODS OF THEIR USE' [patent_app_type] => utility [patent_app_number] => 13/925981 [patent_app_country] => US [patent_app_date] => 2013-06-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 23599 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13925981 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/925981
Sodium glucose co-transporter inhibitors and methods of their use Jun 24, 2013 Issued
Array ( [id] => 9122076 [patent_doc_number] => 20130288997 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-10-31 [patent_title] => 'NUCLEOSIDE PHOSPHORAMIDATES' [patent_app_type] => utility [patent_app_number] => 13/925078 [patent_app_country] => US [patent_app_date] => 2013-06-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 40517 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13925078 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/925078
Nucleoside phosphoramidates Jun 23, 2013 Issued
Array ( [id] => 10129403 [patent_doc_number] => 09163230 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-10-20 [patent_title] => 'Chromatography column and method for isolating nucleic acid' [patent_app_type] => utility [patent_app_number] => 13/918979 [patent_app_country] => US [patent_app_date] => 2013-06-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 5110 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 130 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13918979 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/918979
Chromatography column and method for isolating nucleic acid Jun 15, 2013 Issued
Array ( [id] => 11581694 [patent_doc_number] => 09636314 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-05-02 [patent_title] => 'Medicament for treatment of non-insulin dependent diabetes mellitus, hypertension and/or metabolic syndrome' [patent_app_type] => utility [patent_app_number] => 13/917032 [patent_app_country] => US [patent_app_date] => 2013-06-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 24 [patent_no_of_words] => 6904 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13917032 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/917032
Medicament for treatment of non-insulin dependent diabetes mellitus, hypertension and/or metabolic syndrome Jun 12, 2013 Issued
Array ( [id] => 9122179 [patent_doc_number] => 20130289101 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-10-31 [patent_title] => 'THERAPY-ENHANCING GLUCAN' [patent_app_type] => utility [patent_app_number] => 13/913953 [patent_app_country] => US [patent_app_date] => 2013-06-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 12274 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13913953 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/913953
THERAPY-ENHANCING GLUCAN Jun 9, 2013 Abandoned
Array ( [id] => 9055201 [patent_doc_number] => 20130252915 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-09-26 [patent_title] => 'CRYSTALLINE FORMS OF A MACROLIDE, AND USES THEREFOR' [patent_app_type] => utility [patent_app_number] => 13/900147 [patent_app_country] => US [patent_app_date] => 2013-05-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 10104 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13900147 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/900147
Crystalline forms of a macrolide, and uses therefor May 21, 2013 Issued
Array ( [id] => 9148949 [patent_doc_number] => 20130303472 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-11-14 [patent_title] => 'SOLID STATE FORMS OF FIDAXOMYCIN AND PROCESSES FOR PREPARATION THEREOF' [patent_app_type] => utility [patent_app_number] => 13/896711 [patent_app_country] => US [patent_app_date] => 2013-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 9038 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13896711 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/896711
Solid state forms of fidaxomycin and processes for preparation thereof May 16, 2013 Issued
Array ( [id] => 11642147 [patent_doc_number] => 09663503 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-05-30 [patent_title] => '5-[[4-[[morpholin-2-yl]methylamino]-5-(trifluoromethyl)-2-pyridyl]amino]pyrazine-2-carbonitrile and therapeutic uses thereof' [patent_app_type] => utility [patent_app_number] => 14/396338 [patent_app_country] => US [patent_app_date] => 2013-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17864 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14396338 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/396338
5-[[4-[[morpholin-2-yl]methylamino]-5-(trifluoromethyl)-2-pyridyl]amino]pyrazine-2-carbonitrile and therapeutic uses thereof May 13, 2013 Issued
Array ( [id] => 11799840 [patent_doc_number] => 09540635 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-01-10 [patent_title] => 'Buffer for one-step DNA extraction' [patent_app_type] => utility [patent_app_number] => 13/889520 [patent_app_country] => US [patent_app_date] => 2013-05-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2046 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 77 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13889520 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/889520
Buffer for one-step DNA extraction May 7, 2013 Issued
Array ( [id] => 9413812 [patent_doc_number] => 08697849 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-04-15 [patent_title] => 'Pyrazole compounds' [patent_app_type] => utility [patent_app_number] => 13/875314 [patent_app_country] => US [patent_app_date] => 2013-05-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9124 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13875314 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/875314
Pyrazole compounds May 1, 2013 Issued
Array ( [id] => 9043025 [patent_doc_number] => 20130245663 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-09-19 [patent_title] => 'Devices, Systems and Methods for Treatment of Eating Disorders' [patent_app_type] => utility [patent_app_number] => 13/875086 [patent_app_country] => US [patent_app_date] => 2013-05-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 9601 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13875086 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/875086
Devices, Systems and Methods for Treatment of Eating Disorders Apr 30, 2013 Abandoned
Array ( [id] => 9034860 [patent_doc_number] => 20130237498 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-09-12 [patent_title] => 'METHODS OF USE OF BIOMATERIAL AND INJECTABLE IMPLANT CONTAINING BIOMATERIAL' [patent_app_type] => utility [patent_app_number] => 13/869559 [patent_app_country] => US [patent_app_date] => 2013-04-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 3644 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13869559 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/869559
Methods of use of biomaterial and injectable implant containing biomaterial Apr 23, 2013 Issued
Array ( [id] => 9212582 [patent_doc_number] => 20140011759 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-01-09 [patent_title] => 'COMPOSITIONS AND METHODS OF TREATMENT OF DRUG RESISTANT CANCERS' [patent_app_type] => utility [patent_app_number] => 13/869012 [patent_app_country] => US [patent_app_date] => 2013-04-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 44 [patent_figures_cnt] => 44 [patent_no_of_words] => 18854 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13869012 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/869012
Compositions and methods of treatment of drug resistant cancers Apr 22, 2013 Issued
Array ( [id] => 9895965 [patent_doc_number] => 20150051163 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-02-19 [patent_title] => 'COMBINATION THERAPY FOR TREATING CANCER' [patent_app_type] => utility [patent_app_number] => 14/394463 [patent_app_country] => US [patent_app_date] => 2013-04-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 41101 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14394463 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/394463
Combination therapy for treating cancer Apr 11, 2013 Issued
Array ( [id] => 9015571 [patent_doc_number] => 20130230535 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-09-05 [patent_title] => 'THERAPY-ENHANCING GLUCAN' [patent_app_type] => utility [patent_app_number] => 13/859096 [patent_app_country] => US [patent_app_date] => 2013-04-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 37 [patent_figures_cnt] => 37 [patent_no_of_words] => 24254 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13859096 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/859096
Therapy-enhancing glucan Apr 8, 2013 Issued
Array ( [id] => 10414330 [patent_doc_number] => 20150299340 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-10-22 [patent_title] => 'PREPARATION OF NEW INTERMEDIATE OF HEPARIN PENTASACCHARIDE AND PREPARATION METHOD THEREOF' [patent_app_type] => utility [patent_app_number] => 14/389806 [patent_app_country] => US [patent_app_date] => 2013-04-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 4444 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14389806 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/389806
Preparation of new intermediate of heparin pentasaccharide and preparation method thereof Apr 1, 2013 Issued
Array ( [id] => 9917749 [patent_doc_number] => 20150072954 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-03-12 [patent_title] => 'PHARMACEUTICAL FORMULATIONS COMPRISING CHONDROITIN SULFATE AND HYALURONIC ACID DERIVATIVES' [patent_app_type] => utility [patent_app_number] => 14/389301 [patent_app_country] => US [patent_app_date] => 2013-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 4687 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14389301 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/389301
Pharmaceutical formulations comprising chondroitin sulfate and hyaluronic acid derivatives Mar 26, 2013 Issued
Array ( [id] => 9198774 [patent_doc_number] => 20130338089 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-12-19 [patent_title] => 'METHODS AND COMPOUNDS FOR MODULATING THE SECRETION OR EXPRESSION OF ADHESION PROTEINS OR ANGIOPOIETINS OF CELLS' [patent_app_type] => utility [patent_app_number] => 13/841053 [patent_app_country] => US [patent_app_date] => 2013-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 45 [patent_figures_cnt] => 45 [patent_no_of_words] => 42574 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13841053 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/841053
Methods and compounds for modulating the secretion or expression of adhesion proteins or angiopoietins of cells Mar 14, 2013 Issued
Array ( [id] => 9055200 [patent_doc_number] => 20130252914 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-09-26 [patent_title] => 'Macrolide Polymorphs, Compositions Comprising Such Polymorphs, and Methods of Use and Manufacture Thereof' [patent_app_type] => utility [patent_app_number] => 13/839299 [patent_app_country] => US [patent_app_date] => 2013-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 12893 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13839299 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/839299
Macrolide Polymorphs, Compositions Comprising Such Polymorphs, and Methods of Use and Manufacture Thereof Mar 14, 2013 Abandoned
Menu